Literature DB >> 25736724

Ablation of typical atrial flutter using a non-fluoroscopic catheter tracking system vs. conventional fluoroscopy--results from a prospective randomized study.

Katharina Schoene1, Sascha Rolf2, Denis Schloma2, Silke John2, Arash Arya2, Borislav Dinov2, Sergio Richter2, Andreas Bollmann2, Gerhard Hindricks2, Philipp Sommer2.   

Abstract

AIMS: Reduction of radiation exposure using a sensor-based non-fluoroscopic catheter tracking (NFCT) system (MediGuide™, St Jude Medical, Inc.) was recently demonstrated by retrospective comparisons. We aimed to prospectively compare the effects of using NFCT vs. standard fluoroscopy on procedural parameters in patients undergoing radiofrequency ablation of typical atrial flutter. METHODS AND
RESULTS: We prospectively randomized 40 patients undergoing cavotricuspid isthmus ablation for typical atrial flutter to either NFCT (n = 20) or conventional fluoroscopy (CONV, n = 20). Procedural parameters such as fluoroscopy time, radiation dose, and procedure duration, as well as periprocedural complications were compared. There were no statistically significant differences in baseline characteristics between the two groups. Bidirectional isthmus block was achieved in all patients. Fluoroscopy time was significantly reduced in the NFCT group {0.3 [inter-quartile range (IQR) 0.2; 0.48] min} when compared with CONV [5.7 (IQR 4.2; 11.5) min] (P < 0.001). This resulted in a significant reduction in radiation dose in patients randomized to NFCT [17.4 (IQR 11; 206.6) cGy cm(2)] vs. the CONV group [418.4 (IQR 277; 812.2) cGy cm(2)] (P < 0.001). There were no significant differences in procedure duration between the NFCT group [49.5 (IQR 37; 65) min] when compared with the CONV group [33.5 (IQR 26.3; 55.5) min] (P = 0.053). No adverse events were recorded. Freedom from atrial flutter at 6 months of follow-up was 19/20 (95%) in the NFCT and 18/20 (90%) in the CONV group (n.s.).
CONCLUSION: In this first prospective randomized study, by comparing NFCT with standard fluoroscopy in patients undergoing radiofrequency ablation of typical atrial flutter, NFCT significantly reduced both radiation dose and fluoroscopy time with no effects on procedural duration. These findings support the incorporation of NFCT in routine clinical use. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2015. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Ablation; Non-fluoroscopic tracking system; Radiation time; Typical atrial flutter

Mesh:

Year:  2015        PMID: 25736724     DOI: 10.1093/europace/euu398

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  6 in total

1.  A case of torsades de pointes due to takotsubo cardiomyopathy after common atrial flutter ablation.

Authors:  Yoichiro Nakagawa; Hiroshi Furusho; Yusuke Kamiya; Ryo Nishikawa; Kenji Miwa; Toshihiko Yasuda
Journal:  J Cardiol Cases       Date:  2021-11-25

2.  Zero and Minimal Fluoroscopic Approaches During Ablation of Supraventricular Tachycardias: A Systematic Review and Meta-Analysis.

Authors:  Dorottya Debreceni; Kristof Janosi; Mate Vamos; Andras Komocsi; Tamas Simor; Peter Kupo
Journal:  Front Cardiovasc Med       Date:  2022-04-11

3.  Routine use of intracardiac echocardiography for atrial flutter ablation is associated with reduced fluoroscopy time, but not with a reduction of radiofrequency energy delivery time.

Authors:  Dalibor Herman; Pavel Osmancik; Jana Zdarska; Radka Prochazkova
Journal:  J Atr Fibrillation       Date:  2017-08-31

4.  Maximum voltage gradient technique for optimization of ablation for typical atrial flutter with zero-fluoroscopy approach.

Authors:  Karol Deutsch; Janusz Śledź; Mariusz Mazij; Bartosz Ludwik; Michał Labus; Dariusz Karbarz; Bernadetta Pasicka; Michał Chrabąszcz; Arkadiusz Śledź; Monika Klank-Szafran; Laura Vitali-Sendoz; Tomasz Kameczura; Jerzy Śpikowski; Piotr Stec; Marek Ujda; Sebastian Stec
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

5.  Near zerO fluoroscopic exPosure during catheter ablAtion of supRavenTricular arrhYthmias: the NO-PARTY multicentre randomized trial.

Authors:  Michela Casella; Antonio Dello Russo; Gemma Pelargonio; Maurizio Del Greco; Gianluca Zingarini; Marcello Piacenti; Andrea Di Cori; Victor Casula; Massimiliano Marini; Francesca Pizzamiglio; Martina Zucchetti; Stefania Riva; Eleonora Russo; Maria Lucia Narducci; Ezio Soldati; Luca Panchetti; Umberto Startari; Gianluigi Bencardino; Francesco Perna; Pasquale Santangeli; Luigi Di Biase; Fabrizio Cichocki; Giovanni Fattore; Mariagrazia Bongiorni; Eugenio Picano; Andrea Natale; Claudio Tondo
Journal:  Europace       Date:  2015-11-10       Impact factor: 5.214

6.  First experience with zero-fluoroscopic ablation for supraventricular tachycardias using a novel impedance and magnetic-field-based mapping system.

Authors:  Katie A Walsh; Joseph Galvin; John Keaney; Edward Keelan; Gabor Szeplaki
Journal:  Clin Res Cardiol       Date:  2018-02-23       Impact factor: 5.460

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.